bf/NYSE:EW_icon.jpeg

COM:EDWARDS

Edwards Lifesciences Corporation

  • Stock

Last Close

69.54

21/11 21:00

Market Cap

56.51B

Beta: -

Volume Today

2.70M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
294.95M
-
302.85M
2.68%
318.35M
5.12%
368.25M
15.67%
475.75M
29.19%
580.95M
22.11%
623.95M
7.40%
721.60M
15.65%
764.50M
5.95%
801.10M
4.79%
average payables
61.55M
-
53.30M
13.40%
61.05M
14.54%
80.50M
31.86%
106.85M
32.73%
125.30M
17.27%
157.20M
25.46%
188.45M
19.88%
200.50M
6.39%
203.20M
1.35%
average receivables
337.75M
-
326.50M
3.33%
334.55M
2.47%
379.35M
13.39%
438.40M
15.57%
499.75M
13.99%
568.20M
13.70%
600.95M
5.76%
633.85M
5.47%
682M
7.60%
book value per share
2.33
-
3.43
47.41%
3.87
12.90%
4.10
5.86%
4.73
15.48%
5.00
5.72%
6.64
32.69%
7.35
10.66%
9.36
27.44%
9.38
0.19%
capex per share
-0.16
-
-0.15
10.74%
-0.16
12.34%
-0.34
106.53%
-0.28
18.47%
-0.39
38.84%
-0.45
15.70%
-0.65
46.82%
-0.53
19.12%
-0.43
19.15%
capex to depreciation
-1.60
-
-1.37
14.77%
-1.62
18.50%
-3.05
88.65%
-2.14
29.82%
-3.12
45.73%
-3.12
0.17%
-3.80
21.87%
-2.45
35.61%
-1.90
22.47%
capex to operating cash flow
-0.23
-
-0.09
60.65%
-0.19
111.38%
-0.31
59.30%
-0.18
43.18%
-0.26
48.70%
-0.24
9.49%
-0.39
63.66%
-0.19
50.71%
-0.22
14.16%
capex to revenue
-0.05
-
-0.04
25.06%
-0.04
5.88%
-0.07
71.76%
-0.05
30.36%
-0.06
27.09%
-0.06
1.38%
-0.09
45.02%
-0.06
32.12%
-0.05
21.95%
cash per share
1.40
-
2.25
61.07%
1.89
15.87%
1.99
5.01%
2.11
6.27%
1.52
27.90%
2.43
59.30%
2.25
7.21%
2.35
4.46%
1.96
16.57%
days of inventory on hand
215.83
-
173.16
19.77%
201.01
16.08%
181.54
9.69%
231.39
27.46%
235.85
1.92%
209.91
11.00%
271.00
29.10%
212.38
21.63%
295.78
39.27%
days payables outstanding
33.82
-
33.96
0.41%
37.79
11.29%
44.45
17.62%
48.62
9.40%
52.07
7.08%
59.09
13.49%
66.37
12.33%
59.77
9.95%
68.21
14.13%
days sales outstanding
58.53
-
51.07
12.75%
50.37
1.37%
51.06
1.38%
49.11
3.82%
52.68
7.27%
50.29
4.53%
50.16
0.26%
46.38
7.54%
47.41
2.22%
debt to assets
0.22
-
0.17
22.04%
0.15
12.92%
0.18
23.37%
0.18
0.21%
0.11
38.69%
0.10
6.20%
0.10
8.22%
0.08
15.45%
0.08
2.68%
debt to equity
0.38
-
0.27
28.25%
0.24
12.19%
0.31
31.01%
0.35
10.22%
0.19
45.36%
0.16
13.46%
0.15
7.16%
0.12
22.14%
0.12
0.65%
dividend yield
0.18
-
0.02
90.61%
0.00
88.94%
0.01
588.49%
0.02
-
0.00
98.19%
earnings yield
0.05
-
0.06
12.12%
0.03
51.37%
0.03
1.87%
0.03
8.28%
0.02
13.88%
0.02
4.40%
0.01
32.72%
0.02
28.41%
0.03
77.03%
0.03
8.01%
enterprise value
7.52B
-
13.51B
79.70%
16.90B
25.10%
19.85B
17.45%
23.99B
20.85%
31.92B
33.08%
48.09B
50.63%
56.31B
17.11%
80.58B
43.09%
46.11B
42.78%
enterprise value over ebitda
19.42
-
-76.37
493.34%
26.01
134.06%
22.42
13.82%
24.00
7.06%
22.96
4.33%
36.14
57.37%
32.44
10.22%
54.32
67.43%
25.20
53.62%
ev to operating cash flow
15.90
-
13.22
16.91%
30.75
132.66%
28.18
8.35%
23.97
14.93%
34.44
43.69%
40.77
18.37%
53.41
31.00%
46.52
12.90%
37.85
18.64%
ev to sales
3.68
-
5.82
58.24%
6.78
16.53%
6.70
1.18%
6.98
4.26%
8.57
22.80%
11.06
28.97%
12.84
16.08%
15.40
19.95%
8.57
44.37%
free cash flow per share
0.54
-
1.45
168.60%
0.69
52.83%
0.76
11.17%
1.30
71.13%
1.09
16.30%
1.44
32.10%
1.04
27.94%
2.25
116.50%
1.54
31.54%
0.01
99.44%
free cash flow yield
0.05
-
0.07
38.66%
0.03
61.96%
0.02
6.29%
0.03
42.27%
0.02
38.41%
0.02
13.27%
0.01
38.57%
0.02
52.46%
0.02
18.87%
0.00
99.46%
graham net net
0.26
-
0.78
203.97%
0.15
80.84%
-0.17
215.98%
-1.17
575.62%
-0.83
29.13%
-0.09
89.74%
-0.65
668.73%
-0.54
17.07%
-0.50
8.08%
graham number
5.53
-
9.90
78.93%
8.17
17.49%
9.07
11.02%
10.23
12.87%
11.38
11.23%
15.82
39.00%
14.79
6.54%
22.54
52.44%
22.78
1.07%
income quality
1.21
-
1.26
4.44%
1.11
11.87%
1.24
11.36%
1.71
38.63%
1.28
25.16%
1.13
12.21%
1.28
13.66%
1.15
10.00%
0.80
30.54%
intangibles to total assets
0.16
-
0.11
30.23%
0.21
81.23%
0.18
10.30%
0.28
51.93%
0.27
2.33%
0.23
15.20%
0.21
10.33%
0.18
15.62%
0.17
0.35%
0
100%
interest coverage
87.40
-
44.69
48.88%
69.11
54.65%
93.31
35.02%
352.66
277.94%
-356.29
201.03%
55.40
115.55%
103.06
86.03%
73.29
28.89%
91.07
24.26%
interest debt per share
0.89
-
0.95
6.74%
0.94
1.11%
1.30
37.96%
1.64
26.36%
0.94
42.60%
1.12
18.75%
1.14
1.96%
1.14
0.39%
1.15
0.95%
inventory turnover
1.69
-
2.11
24.64%
1.82
13.85%
2.01
10.73%
1.58
21.55%
1.55
1.89%
1.74
12.35%
1.35
22.54%
1.72
27.60%
1.23
28.19%
invested capital
0.38
-
0.27
28.25%
0.24
12.19%
0.31
31.01%
0.35
10.22%
0.19
45.36%
0.16
13.46%
0.15
7.16%
0.12
22.14%
0.12
0.65%
market cap
7.35B
-
13.57B
84.69%
17.02B
25.46%
19.96B
17.26%
23.77B
19.10%
32.04B
34.80%
48.59B
51.63%
56.80B
16.90%
80.75B
42.16%
46.18B
42.81%
46.26B
0.17%
net current asset value
560.30M
-
961.70M
71.64%
491.70M
48.87%
349M
29.02%
-169.70M
148.62%
103.60M
161.05%
644.20M
521.81%
428.20M
33.53%
514M
20.04%
610M
18.68%
net debt to ebitda
0.45
-
0.31
29.41%
-0.18
157.93%
-0.12
33.25%
0.22
279.24%
-0.09
139.66%
-0.38
334.47%
-0.28
25.17%
-0.12
58.66%
-0.04
63.49%
net income per share
0.58
-
1.27
117.18%
0.77
39.69%
0.89
16.42%
0.98
10.32%
1.15
17.03%
1.68
45.61%
1.32
21.07%
2.41
82.34%
2.46
1.95%
2.31
5.98%
operating cash flow per share
0.71
-
1.60
126.83%
0.85
46.85%
1.10
29.65%
1.58
43.48%
1.48
6.63%
1.89
27.83%
1.69
10.29%
2.78
64.10%
1.97
29.18%
0.01
99.56%
payables turnover
10.79
-
10.75
0.41%
9.66
10.14%
8.21
14.98%
7.51
8.59%
7.01
6.61%
6.18
11.88%
5.50
10.98%
6.11
11.05%
5.35
12.38%
receivables turnover
6.24
-
7.15
14.61%
7.25
1.39%
7.15
1.36%
7.43
3.98%
6.93
6.78%
7.26
4.75%
7.28
0.26%
7.87
8.15%
7.70
2.17%
research and ddevelopement to revenue
0.16
-
0.15
5.54%
0.15
2.99%
0.15
2.64%
0.16
7.54%
0.17
3.90%
0.17
3.58%
0.17
0.18%
0.17
0.48%
0.18
1.75%
0.18
1.64%
return on tangible assets
0.17
-
0.26
51.22%
0.15
40.89%
0.15
0.89%
0.15
2.03%
0.19
23.10%
0.21
12.51%
0.14
31.62%
0.21
49.26%
0.22
3.74%
revenue per share
3.05
-
3.64
19.11%
3.86
6.11%
4.64
20.24%
5.43
17.07%
5.93
9.25%
6.96
17.32%
7.05
1.24%
8.39
19.16%
8.70
3.58%
9.90
13.83%
roe
0.25
-
0.37
47.33%
0.20
46.58%
0.22
9.98%
0.21
4.47%
0.23
10.70%
0.25
9.74%
0.18
28.67%
0.26
43.08%
0.26
1.76%
roic
0.16
-
0.12
23.58%
0.16
34.27%
0.18
6.73%
0.15
13.24%
0.19
24.62%
0.21
10.26%
0.27
30.00%
0.18
33.97%
0.23
26.96%
sales general and administrative to revenue
0.36
-
0.37
1.33%
0.34
7.64%
0.31
10.52%
0.29
6.10%
0.29
2.00%
shareholders equity per share
2.33
-
3.43
47.41%
3.87
12.90%
4.10
5.86%
4.73
15.48%
5.00
5.72%
6.64
32.69%
7.35
10.66%
9.36
27.44%
9.38
0.19%
stock based compensation to revenue
0.02
-
0.02
10.27%
0.02
3.76%
0.02
4.06%
0.02
6.60%
0.02
6.36%
0.02
1.96%
0.02
12.90%
0.02
1.05%
0.02
12.78%
tangible asset value
1.12B
-
1.79B
60.49%
1.67B
6.84%
1.79B
7.11%
1.40B
21.69%
1.69B
20.34%
2.64B
56.92%
3.07B
16.10%
4.34B
41.53%
4.36B
0.29%
tangible book value per share
1.67
-
2.80
68.32%
2.58
7.92%
2.80
8.37%
2.21
20.91%
2.68
21.32%
4.23
57.62%
4.93
16.51%
6.97
41.37%
7.04
0.99%
working capital
1.38B
-
1.86B
34.78%
1.57B
15.51%
1.71B
8.64%
1.13B
33.66%
1.41B
24.51%
2.08B
47.60%
2.20B
5.55%
2.15B
2.22%
2.07B
3.49%

All numbers in (except ratios and percentages)